Amphastar Pharmaceuticals, Inc.
$1.32B- Market cap
- $986.03M
- Debt
- +$619.71M
- Cash
- −$282.81M
Capital structure 61% equity / 39% debt · EV / Revenue 1.84x · EV / EBITDA 6.20x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AMPH · current priceP/E 11.42x
$23.18Latest market snapshot
Implied fair value · at BELFA's multiple
$14.5237.3% below market
2.03 AMPH EPS (TTM)×7.15x BELFA P/E=$14.52
Market $23.18Implied $14.52
BELFA · current priceP/E 7.15x
$202.42Latest market snapshot
Implied fair value · at AMPH's multiple
$323.0859.6% above market
28.29 BELFA EPS (TTM)×11.42x AMPH P/E=$323.08
Market $202.42Implied $323.08